delta(3)-chromene-3-carboxamide

Suppliers

Names

[ CAS No. ]:
10185-00-9

[ Name ]:
delta(3)-chromene-3-carboxamide

[Synonym ]:
2H-Chromen-3-carboxamid
Compound 69/20
2H-1-BENZOPYRAN-3-CARBOXAMIDE
2H-chromene-3-carboxylic acid amide
Chromene-3-carboxamide
3-Carbamoyl-2H-benzopyran

Chemical & Physical Properties

[ Density]:
1.278g/cm3

[ Boiling Point ]:
413.5ºC at 760mmHg

[ Molecular Formula ]:
C10H9NO2

[ Molecular Weight ]:
175.18400

[ Exact Mass ]:
175.06300

[ PSA ]:
53.31000

[ LogP ]:
2.09740

[ Vapour Pressure ]:
4.76E-07mmHg at 25°C

[ Index of Refraction ]:
1.613

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
DJ2252000
CHEMICAL NAME :
2H-1-Benzopyran-3-carboxamide
CAS REGISTRY NUMBER :
10185-00-9
BEILSTEIN REFERENCE NO. :
1369323
LAST UPDATED :
199612
DATA ITEMS CITED :
2
MOLECULAR FORMULA :
C10-H9-N-O2
MOLECULAR WEIGHT :
175.20

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
850 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
DRFUD4 Drugs of the Future. (J.R. Prous, S.A., Apartado de Correos 540, 08080 Barcelona, Spain) V.1- 1975/76- Volume(issue)/page/year: 7,547,1982
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
550 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
DRFUD4 Drugs of the Future. (J.R. Prous, S.A., Apartado de Correos 540, 08080 Barcelona, Spain) V.1- 1975/76- Volume(issue)/page/year: 7,547,1982

Safety Information

[ HS Code ]:
2924199090

Synthetic Route

Click to get detail synthetic route

Customs

[ HS Code ]: 2924199090

[ Summary ]:
2924199090. other acyclic amides (including acyclic carbamates) and their derivatives; salts thereof. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0%

Related Compounds

  • N-(3-chlorophenyl)-2-oxo-2H-chromene-3-carboxamide
  • N-(3,4-dimethylphenyl)-2-oxo-2H-chromene-3-carboxamide
  • N-(3-aminonaphthalen-2-yl)-2-oxo-2H-chromene-3-carboxamide
  • N-(3-Chloro-4-methylphenyl)-6-methoxy-2-oxo-2H-chromene-3-carboxamide
  • N-(3-Chloro-2-methylphenyl)-6-nitro-2-oxo-2H-chromene-3-carboxamide
  • N-(3-Chloro-4-methylphenyl)-6-nitro-2-oxo-2H-chromene-3-carboxamide
  • 1-{2-Tert-butylimidazo[1,2-b]pyridazin-6-yl}-4-(2-cyclopropyl-6-methylpyrimidin-4-yl)-1,4-diazepane
  • 1-ethyl-3,5-dimethyl-4-{6H,7H,8H,9H-pyrido[2,3-b]1,6-naphthyridine-7-sulfonyl}-1H-pyrazole
  • 1-methyl-2-{6H,7H,8H,9H-pyrido[2,3-b]1,6-naphthyridine-7-sulfonyl}-1H-imidazole
  • 4-phenyl-2-(3-{[2-(propan-2-yl)-1H-imidazol-1-yl]methyl}azetidin-1-yl)-1,3-thiazole
  • 12-[4-(3,6-Dimethylpyrazin-2-yl)oxypiperidin-1-yl]-7-thia-9,11-diazatricyclo[6.4.0.02,6]dodeca-1(12),2(6),8,10-tetraene
  • 2-(3-methoxyphenoxy)-1-{6H,7H,8H,9H-pyrido[2,3-b]1,6-naphthyridin-7-yl}ethan-1-one
  • 2-{4-[(3,6-dimethylpyrazin-2-yl)oxy]piperidin-1-yl}-N-(prop-2-en-1-yl)acetamide
  • 3-[({2-tert-butylimidazo[1,2-b]pyridazin-6-yl}oxy)methyl]-1-{5H,6H,7H-cyclopenta[d]pyrimidin-4-yl}pyrrolidine
  • N-[2-(4-methoxyphenyl)ethyl]-N-methylpyrazolo[1,5-a]pyrazin-4-amine
  • 2-[4-(4-methanesulfonylphenyl)piperazin-1-yl]-6-(1-methyl-1H-pyrazol-4-yl)pyrazine
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.